Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Apr 28, 2024, 16:36 |
Blog
FDA Oncology: OCE's Project Facilitate processed 401 calls and 889 applications for oncology investigational drugs
FDA Oncology shared a post on X: "In 2023, OCE's Project Facilitate handled 401 phone…
Apr 28, 2024, 13:23 |
Drugs
Sam Blackman: US FDA approved the first targeted medicine for the treatment of patients with relapsed or refractory pediatric low-grade glioma
Sam Blackman, Co-founder and Chief Medical Officer of Day One Biopharmaceuticals, shared a post by Day…
Apr 26, 2024, 11:03 |
Blog
Vivek Subbiah: FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
Vivek Subbiah shared a post on X: "FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive…
Apr 26, 2024, 10:07 |
Drugs
Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer
Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: ''HOT OFF…
Apr 24, 2024, 22:44 |
Blog
Amol Akhade: Can u pronounce name of this latest approved drug by US FDA correctly?
Amol Akhade, Consultant medical oncologist at Suyog Cancer Clinics, shared a post on X: "Can u…
Apr 24, 2024, 17:24 |
Blog
U.S. FDA approved the first targeted medicine for the treatment of patients with relapsed or refractory pediatric low-grade glioma - Day One Biopharmaceuticals
Day One Biopharmaceuticals shared a post on LinkedIn: "Breaking News: Today, we are thrilled to share…
Apr 24, 2024, 09:13 |
Drugs
FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
FDA, the Food and Drug Administration, approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with…
Apr 21, 2024, 23:34 |
Blog
Svetlana Nikic: Comprehensive and structured list of FDA-approved CDx NGS assays. Super easy to be found at FDA's website
Svetlana Nikic, Founder of Precision Oncology Consulting, shared a post on LinkedIn: "With an overwhelming amount…
Apr 21, 2024, 21:08 |
Insight
Alison Silberman is one of the FDA Oncology panelists for the upcoming Conversations on Cancer
FDA Oncology shared on X: “Alison Silberman is one of our panelists for the upcoming conversations…
Apr 21, 2024, 07:21 |
Blog
Julia Maués: Look who’s being highlighted in the latest edition of FDA Oncology Project Community newsletter!
Julia Maués, Co-Founder of Grasp Cancer, shared a post on X/Twitter by Barbara Segarra, Professor…
14
15
16
17
18
All:
937
Posts:
151 - 160
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube